Upcoming Allied Market Research
Polycythemia Vera Market

Polycythemia Vera Market

Size, Share, Competitive Landscape and Trend Analysis Report by  Route of Administration (Oral, Parenteral), by Type (Dasatinib    , Idelalisib, Givinostat, M-009, Others), by  Population (Children  , Adults), by Treatment   (Phlebotomy, Drug Therapy) and by End User   (Hospitals, Specialty Clinics, Diagnostic Centers  , Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A13437
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Polycythemia vera (PV) is a syndrome characterized by an increase in the number of red blood cells in the bloodstream acquired from various sources. Visible symptoms include itching, headache, dizziness, fatigue, blind spots, leukemia, and even heart attack in a few cases due to an unusual thrombotic event. As per reports, the disease is known to occur in men more often above the age of 60. Comorbidities of polycythemia vera include peptic ulcers, blood clots, gout, acute myeloid leukemia, myelodysplastic syndrome, and splenomegaly. In the absence of a proper therapy, survival rates in patients suffering from the disease comes down to as low as 3 years with the number stretching to 14 years for patients with a healthy metabolism.

 The diagnosis consists of testing the bloodstream for presence of excess levels of a hormone known as erythropoietin as well as mutations in JAK2. As a first line diagnostics procedure, the professional may perform a procedure known as complete blood count to see whether the number of red blood cells are higher than normal. Treatment of polycythemia consists of a blood thinning techniques such as phlebotomy and low-dose aspirin. Phlebotomy helps in reduction in the possibility of life threatening events such as heart attack, stroke, pulmonary embolism, acute leukemia, and hypertension.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the polycythemia vera market.

Top Impacting Factors

  • Increase in the occurrence of the disease aided by rising healthcare spending by industrialized and newly commercialized economies and general rising awareness across people will give a major boost to the growth of the market.
  • Recent launch of drugs such as   PTG-300, IM-7289 coupled with more product approvals is a major driver for the growth of polycythemia treatment market.
  • Higher government spending in addition to the increased focus toward targeted therapies provides a positive impetus for exponential market growth.
  • Overall growing ecological anxiety due to psychological impact of COVID-19 and the subsequent exposure to toxic compounds is another driver of the polycythemia vera treatment market.
  • However, higher cost of product lined with stringent regulatory and reimbursement policies by conservative governments across the globe restrain the market growth.

Key Market Trends

  • North America continues to govern the market, owing to highest number of polycythemia vera cases among all the nations coupled with higher diagnosis rate due to presence of robust infrastructure.
  • An interferon-alpha 2b stimulant which goes by the name of “Besremi” has recently been approved by G7 countries, and is stipulated to enter the market as the first line of defense against polycythemia vera soon.
  • Among many polycythemia vera emerging therapies focused on second line defense, Protagonist Therapeutics and Imago Biosciences are in line to enter the market with their newly manufactured products.
  • Jakafi is poised to establish and maintain dominance in the hydroxyl-urea refractory market, thus primarily focusing on the second line defense mechanisms.
  • On the basis of various distribution and communication channels, health center drug stores are poised to remain as the most successful sector in polycythemia vera market.
  • The outbreak of the novel coronavirus and shift in focus on handling the supply chains during the pandemic have led to delay and suspension of critical product trails and approvals until the situation subsides, thus leading to heavy losses to major private sector players.

Key Benefits of the Report

  • This study presents the analytical depiction of the polycythemia vera industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the polycythemia vera market share.
  • The current market is quantitatively analyzed to highlight the polycythemia vera market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the polycythemia vera market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in the Polycythemia vera Report

  • Which are the leading players active in the polycythemia vera market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the polycythemia vera market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the polycythemia vera market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is polycythemia vera?
  • What is the polycythemia vera market prediction in the future?
  • What are the current trends and predicted trends?

Polycythemia Vera Market Report Highlights

Aspects Details
By  Route of Administration
  • Oral
  • Parenteral
By Type
  • Dasatinib    
  • Idelalisib
  • Givinostat
  • M-009
  • Others
By  Population
  • Children  
  • Adults
By Treatment  
  • Phlebotomy
  • Drug Therapy
By End User  
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers  
  • Research Institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Miragen Therapeutics, ANP Technologies, Novartis, Promedior, Hoffman La Roche Ltd, AOP Orphan Pharmaceuticals AG, PharmaEssentiaI, Imago Biosciences, Galena Biopharma, Inc., Jakafi Ltd., Incyte Corporation

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Polycythemia Vera Market

Start reading.
This Report and over 71,321+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers